EverBank Financial Corp. EVER 深 沪
等待开盘 08-01 09:30:00 美东时间
24.58
+0.290
+1.19%
华盛通- 最 高24.93
- 今 开24.47
- 成交量 17.85万股
- 最 低 24.3626
- 昨 收 24.29
- 总市值 8.89亿
- 52周最高 30.03
- 市盈率 静 28.00
- 换手率 0.49%
- 52周最低 16.63
- 委 比 53.85%
- 总股本 3615.65万
- 历史最高 63.44
- 量 比 0.51
- 振 幅 2.34%
- 历史最低 4.05
- 每 手 1
- 风险率 2.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多EverCommerce Announces Date of Second Quarter 2025 Earnings Call
EverCommerce Inc. will release its Q2 2025 financial results on August 6, 2025, after U.S. markets close. Management will host a conference call at 5:00 p.m. ET / 3:00 p.m. MT the same day to discuss the results and provide a business update. A replay will be available on the company's Investor Relations website. EverCommerce is a leading SaaS provider for service-based SMBs, offering tailored solutions to help businesses grow and streamline oper...
07-18 16:00
EverQuote to Announce Second Quarter 2025 Financial Results on August 4, 2025
EverQuote Inc. will announce its Q2 2025 financial results after market close on August 4, 2025. A conference call and webcast to discuss the results, recent developments, and business outlook will be held at 4:30 p.m. ET.
07-14 20:10
云顶新耀午前涨近6% 交银国际上调其目标价至72.50港元
云顶新耀（01952）早盘涨幅扶持扩大，股价上涨5.86%，现报67.80港元，成交额2.92亿港元。 交银国际发布研报指出，云顶新耀近期举办研发日活动，集中展...
07-04 11:41
交银国际：升云顶新耀(01952.HK)目标价至72.5港元 维持“买入”评级
交银国际发布研报称，将云顶新耀(01952.HK)的EVER001加入长期财务预测中，预计其经PoS调整后的销售峰值将超过15亿元人民币，上调其目标价至72.5港元，对应237亿港元目标估值和1.8倍收入达峰时的市销率，维持买入评级。
07-03 10:50
云顶新耀早盘涨超5% 宣布EVER001治疗原发性膜性肾病临床试验数据取得积极结果
云顶新耀（01952）早盘股价上涨5.15%，现报65.40港元，成交额3.77亿港元。 据云顶新耀官微消息，7月1日，云顶新耀宣布新一代共价可逆布鲁顿酪氨...
07-02 10:28
中金：维持云顶新耀“跑赢行业”评级 升目标价至80港元
中金发布研报称，维持云顶新耀（01952）2025年和2026年盈利预测基本不变。基于DCF估值法，维持跑赢行业评级，由于公司开始与海外药企洽谈mRNA技术...
07-01 17:11
Winning And Losing Stocks From Tesla's Driverless Taxi Test
You may not have noticed, but on Sunday, June 22, the world of cars changed for...
06-28 02:11
RFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
CDC panel backs Merck's Enflonsia for RSV prevention in infants; FDA-approved therapy reduced hospitalizations by 84% in clinical trials.
06-27 19:56
